These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 31132340)
1. Progestogens for the prevention of preterm birth and risk of developing gestational diabetes mellitus: a meta-analysis. Pergialiotis V; Bellos I; Hatziagelaki E; Antsaklis A; Loutradis D; Daskalakis G Am J Obstet Gynecol; 2019 Nov; 221(5):429-436.e5. PubMed ID: 31132340 [TBL] [Abstract][Full Text] [Related]
2. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis. Boelig RC; Locci M; Saccone G; Gragnano E; Berghella V Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100658. PubMed ID: 35562009 [TBL] [Abstract][Full Text] [Related]
3. Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and metaanalysis of randomized controlled trials. Quist-Nelson J; Parker P; Mokhtari N; Di Sarno R; Saccone G; Berghella V Am J Obstet Gynecol; 2018 Oct; 219(4):346-355.e2. PubMed ID: 29614278 [TBL] [Abstract][Full Text] [Related]
4. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety. O'Brien JM; Lewis DF Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340 [TBL] [Abstract][Full Text] [Related]
5. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study. Nelson DB; McIntire DD; McDonald J; Gard J; Turrichi P; Leveno KJ Am J Obstet Gynecol; 2017 Jun; 216(6):600.e1-600.e9. PubMed ID: 28223163 [TBL] [Abstract][Full Text] [Related]
6. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. EPPPIC Group Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery. Oler E; Eke AC; Hesson A Int J Gynaecol Obstet; 2017 Jul; 138(1):12-16. PubMed ID: 28369874 [TBL] [Abstract][Full Text] [Related]
8. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial. Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093 [TBL] [Abstract][Full Text] [Related]
9. 17α-Hydroxyprogesterone Caproate and the Risk of Glucose Intolerance in Pregnancy: A Systematic Review and Meta-analysis. Eke AC; Sheffield J; Graham EM Obstet Gynecol; 2019 Mar; 133(3):468-475. PubMed ID: 30741815 [TBL] [Abstract][Full Text] [Related]
10. Progesterone and preterm birth. Norman JE Int J Gynaecol Obstet; 2020 Jul; 150(1):24-30. PubMed ID: 32524598 [TBL] [Abstract][Full Text] [Related]
14. Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Rebarber A; Istwan NB; Russo-Stieglitz K; Cleary-Goldman J; Rhea DJ; Stanziano GJ; Saltzman DH Diabetes Care; 2007 Sep; 30(9):2277-80. PubMed ID: 17563346 [TBL] [Abstract][Full Text] [Related]
15. Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis. Conde-Agudelo A; Romero R Am J Obstet Gynecol; 2022 Sep; 227(3):440-461.e2. PubMed ID: 35460628 [TBL] [Abstract][Full Text] [Related]
16. A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth. Nelson DB; McIntire DD; Leveno KJ Am J Obstet Gynecol; 2021 Feb; 224(2):175-186. PubMed ID: 33035472 [TBL] [Abstract][Full Text] [Related]
17. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Suhag A; Saccone G; Berghella V Am J Obstet Gynecol; 2015 Oct; 213(4):479-87. PubMed ID: 25797233 [TBL] [Abstract][Full Text] [Related]
18. Vaginal progesterone is associated with decreased group B streptococcus colonisation at term: a retrospective cohort study. Ma'ayeh M; Rood KM; Walker HC; Oliver EA; Gee SE; Iams JD BJOG; 2019 Aug; 126(9):1141-1147. PubMed ID: 31094064 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant 17-hydroxyprogesterone caproate in women with history-indicated cerclage: A systematic review and meta-analysis. Eke AC; Sheffield J; Graham EM Acta Obstet Gynecol Scand; 2019 Feb; 98(2):139-153. PubMed ID: 30339274 [TBL] [Abstract][Full Text] [Related]
20. Progestogens and prevention of preterm birth in women at risk. Prescrire Int; 2016 Jul; 25(173):185-188. PubMed ID: 30730653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]